Loading...

Loading...

J&J, Medtronic, Novo Nordisk in the Spotlight: The Week in Health
By Sofía Garduño - Thu, 07/24/2025 - 08:59
This week J&J files for psoriasis drug, Medtronic expands device use in the European Union, and Novo Nordisk launches an e-commerce store in Mexico.
https://mexicobusiness.news/tag/diabetes-management
More Health
Novo Nordisk to Launch Semaglutide 2.4mg in Mexico
By MBN Staff - Fri, 02/28/2025 - 16:18
Novo Nordisk to launch semaglutide 2.4mg in Mexico for weight management. The drug is designed to aid obesity and overweight treatment.
Late-Night Eating Impairs Glucose Tolerance, Study Finds
By Sofía Garduño - Wed, 11/27/2024 - 08:30
A study shows that late-night eating worsens glucose tolerance in adults with obesity, prediabetes, or Type 2 diabetes, regardless of weight or diet.
Why Latin America Needs Value-Based Healthcare Now
By Hector Barillas - Tue, 09/24/2024 - 12:00
Hector Barillas discusses how VBHC is making waves in some of the world’s most advanced economies and why Latin America cannot afford to lag behind.
Abbott Unveils New Options for Continuous Glucose Monitoring
By MBN Staff - Wed, 06/26/2024 - 14:18
Abbott has received FDA clearance for two new continuous glucose monitoring systems, increasing its portfolio of metabolic health management tools.
WHO Issues Urgent Warning on Counterfeit Diabetes Medication
By MBN Staff - Tue, 06/25/2024 - 13:34
The WHO has issued an urgent alert about counterfeit semaglutide medications, including Ozempic, which are used to treat type 2 diabetes and obesity.
Lilly Launches Diabetes Training Program for Mexican Doctors
By Anmol Motwani - Mon, 06/10/2024 - 10:21
Lilly aims to train 50,000 doctors, enhancing diabetes management and reducing complications nationwide.
Precision Medicine Vital for Tackling Metabolic Syndrome
By María Jesús Salido Rojo - Wed, 12/13/2023 - 09:00
Personalized medicine acknowledges individual patient variations crucial in addressing multifaceted health issues, writes María Salido.